1. Home
  2. IRIX vs PRPO Comparison

IRIX vs PRPO Comparison

Compare IRIX & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • PRPO
  • Stock Information
  • Founded
  • IRIX 1989
  • PRPO N/A
  • Country
  • IRIX United States
  • PRPO United States
  • Employees
  • IRIX N/A
  • PRPO N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • IRIX Health Care
  • PRPO Industrials
  • Exchange
  • IRIX Nasdaq
  • PRPO Nasdaq
  • Market Cap
  • IRIX 20.2M
  • PRPO 22.0M
  • IPO Year
  • IRIX 1996
  • PRPO N/A
  • Fundamental
  • Price
  • IRIX $1.10
  • PRPO $19.55
  • Analyst Decision
  • IRIX
  • PRPO
  • Analyst Count
  • IRIX 0
  • PRPO 0
  • Target Price
  • IRIX N/A
  • PRPO N/A
  • AVG Volume (30 Days)
  • IRIX 65.6K
  • PRPO 19.1K
  • Earning Date
  • IRIX 11-11-2025
  • PRPO 11-05-2025
  • Dividend Yield
  • IRIX N/A
  • PRPO N/A
  • EPS Growth
  • IRIX N/A
  • PRPO N/A
  • EPS
  • IRIX N/A
  • PRPO N/A
  • Revenue
  • IRIX $49,744,000.00
  • PRPO $21,242,000.00
  • Revenue This Year
  • IRIX $9.61
  • PRPO N/A
  • Revenue Next Year
  • IRIX N/A
  • PRPO N/A
  • P/E Ratio
  • IRIX N/A
  • PRPO N/A
  • Revenue Growth
  • IRIX 0.09
  • PRPO 27.05
  • 52 Week Low
  • IRIX $0.78
  • PRPO $3.90
  • 52 Week High
  • IRIX $1.95
  • PRPO $22.38
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 39.76
  • PRPO 61.33
  • Support Level
  • IRIX $1.09
  • PRPO $16.50
  • Resistance Level
  • IRIX $1.23
  • PRPO $21.23
  • Average True Range (ATR)
  • IRIX 0.08
  • PRPO 1.38
  • MACD
  • IRIX -0.01
  • PRPO 0.14
  • Stochastic Oscillator
  • IRIX 16.18
  • PRPO 67.82

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

Share on Social Networks: